Radiation Dose from Mammography
A standard two-view screening mammogram delivers an average mean glandular dose (MGD) of approximately 2.5-3.7 mGy per breast (total ~5-7.4 mGy for bilateral imaging), which translates to roughly 0.4-0.7 millisieverts (mSv) effective dose for the complete examination.
Standard Screening Mammography Dose
The radiation exposure from modern digital mammography is quite low:
- Two-view digital mammography: Average MGD of 3.7 mGy per breast 1
- Four-view bilateral examination: Total dose ranges from 5-7.4 mGy 2, 3
- Effective dose equivalent: Approximately 0.4-0.7 mSv for a complete bilateral screening exam
Recent data from 2023 confirms these values remain consistent, with screening acquisitions showing MGD of 2.44 mGy per view for 2D mammography 2. A 2022 review reported average mean glandular doses around 2.5-3 mGy per view 3.
Diagnostic Mammography Dose
Diagnostic mammograms typically deliver slightly higher doses than screening studies because they often require additional views:
- Diagnostic 2D mammography: NDRL of 1.97 mGy per view 2
- Additional spot compression or magnification views add incremental dose
- Total diagnostic study dose varies based on number of views obtained (typically 4-8 views)
Digital Breast Tomosynthesis (DBT) Considerations
When DBT is combined with standard 2D imaging, radiation exposure considerations change:
- Combined 2D + DBT: Approximately doubles the radiation dose compared to 2D alone 4
- DBT with synthetic 2D: Reduces total dose by eliminating need for separate 2D acquisition 4
- DBT screening: NDRL of 2.30 mGy per view (comparable to standard 2D) 2
- Diagnostic DBT: NDRL of 2.01 mGy per view 2
The U.S. FDA has approved synthetic reconstruction methods that generate 2D images from the 3D DBT dataset, effectively reducing radiation exposure while maintaining diagnostic quality 5.
Clinical Context: Risk vs. Benefit
The radiation risk from screening mammography is extremely small compared to the mortality benefit. Key points for counseling patients:
- Lifetime screening (ages 40-74): Annual screening results in approximately 65 induced cancers and 8 deaths per 100,000 women 3
- Lives saved: 497 deaths prevented from breast cancer per 100,000 screened women 3
- Benefit-to-risk ratio: 62 lives saved for every 1 death from radiation-induced cancer 3
For a single examination, the lifetime attributable risk of fatal breast cancer is approximately 1.3 cases per 100,000 women aged 40 at exposure, decreasing to less than 1 per million for women aged 80 1.
Special Populations
Pregnant women: The fetal radiation dose from a 4-view mammogram is <0.03 mGy (0.03 millisieverts), well below the 50 mGy threshold for teratogenic effects 6. Mammography with lead shielding can be performed safely when clinically indicated.
BRCA carriers and high-risk women under age 30: Due to potential increased radiation sensitivity, breast MRI screening is preferred over mammography 4. The GENE-RAD-RISK study showed increased breast cancer risk in BRCA1/2 carriers exposed to diagnostic radiation before age 30 4.
Common Pitfalls to Avoid
- Don't overestimate the dose: Modern digital mammography uses significantly less radiation than older film-screen systems
- Don't confuse MGD with effective dose: MGD (measured in mGy) is the absorbed dose to glandular tissue; effective dose (measured in mSv) accounts for tissue weighting factors
- Don't unnecessarily avoid mammography in pregnancy: When clinically indicated, the fetal dose is negligible with proper shielding 6
- Don't use radiation concerns to defer appropriate screening: The mortality benefit far outweighs the theoretical radiation risk in appropriate populations 3, 7
The radiation exposure from mammography falls well within acceptable safety limits established by regulatory bodies, and the doses have continued to decrease with advancing technology 4, 5.